Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination
Virology Journal · 13.06.2024 · 21 (1)
DOI: 10.1186/s12985-024-02410-1 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Virology Journal, online erschienen am 13.06.2024. Verfasst von Caroline De Bouver und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19, Immunoglobulin G, Immunoglobulin A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Infection with SARS-CoV-2 in high-risk groups such as kidney transplant and dialysis patients is shown to be associated with a more serious course of the disease. Four years after the start of the COVID-19 pandemic, crucial knowledge on the immune responses in these patient groups is still lacking. Therefore, this study aimed at investigating the humoral immune response after a SARS-CoV-2 infection compared to vaccination as well as the evolution of immunoglobulins over time.
Methods
Kidney transplant recipients, patients on haemodialysis or on peritoneal dialysis and healthy controls were included in this longitudinal multicenter study. SARS-CoV-2 anti-RBD, anti-NP and anti-S1S2 immunoglobulin G (IgG) and A (IgA) as well as the neutralizing antibody capacity were measured.
Results
Kidney transplant recipients had a significantly better humoral response to SARS-CoV-2 after infection (86.4%) than after a two-dose mRNA vaccination (55.8%) while seroconversion was comparable in patients on haemodialysis after infection (95.8%) versus vaccination (89.4%). In individuals without prior COVID-19, the IgG levels after vaccination were significantly lower in kidney transplant recipients when compared to all other groups. However, the IgA titres remained the highest in this patient group at each time point, both after infection and vaccination. A history COVID-19 was associated with higher antibody levels after double-dose vaccination in all patient categories and, while decreasing, titres remained high six months after double-dose vaccination.
Conclusion
Kidney transplant recipients had a more robust humoral response to SARS-CoV-2 following infection compared to a two-dose mRNA vaccination, while patients on haemodialysis exhibited comparable seroconversion rates. Notably, individuals with prior COVID-19 exhibited higher IgG levels in response to vaccination. Hybrid immunity is thus the best possible defence against severe COVID-19 disease and seems also to hold up for these populations. Next, it is not clear whether the higher IgA levels in the kidney transplant recipients is beneficial for neutralizing SARS-CoV-2 or if it is a sign of disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
- Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
- Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, Edegem, Belgium.
- Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.
- Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
- Department of Nephrology-Dialysis, University Hospital (CHU) Ambroise Paré, Mons, Belgium.
Zitieren
APA
De Bouver, C., Bouziotis, J., Wijtvliet, V. P. W. M., Ariën, K. K., Mariën, J., Heyndrickx, L., Couttenye, M. M., de Fijter, H. J. W., Mestrez, F., Treille, S., Mat, O., Collart, F., Allard, S. D., Vingerhoets, L., Moons, P., Abramowicz, D., De Winter, B. Y., Pipeleers, L., Wissing, K. M., & Ledeganck, K. J. (2024). Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination. Virology Journal, 21(1). https://doi.org/10.1186/s12985-024-02410-1
Vancouver
De Bouver C, Bouziotis J, Wijtvliet VPWM, Ariën KK, Mariën J, Heyndrickx L, et al. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination. Virology Journal. 2024;21(1). doi:10.1186/s12985-024-02410-1
BibTeX
@article{DeBouver2024,
author = {De Bouver, Caroline and Bouziotis, Jason and Wijtvliet, Veerle P W M and Ariën, Kevin K and Mariën, Joachim and Heyndrickx, Leo and Couttenye, Marie M and de Fijter, Hans J W and Mestrez, Fabienne and Treille, Serge and Mat, Olivier and Collart, Frederic and Allard, Sabine D and Vingerhoets, Lies and Moons, Pieter and Abramowicz, Daniel and De Winter, Benedicte Y and Pipeleers, Lissa and Wissing, Karl Martin and Ledeganck, Kristien J},
title = {Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination},
journal = {Virology Journal},
year = {2024},
volume = {21},
number = {1},
doi = {10.1186/s12985-024-02410-1}
}
EUVIMED